In fact, GPBAR1 has been recently identified as the physiological mediator of pruritus19, a common symptom observed in cholestasis and the severity of this side effect limits the pharmacological utility of dual agonists in the treatment of primary biliary cirrhosis (PBC) and related cholestatic disorders. This evidence concerns the gene GPBAR1 and cholestasis.